StonvexLoading…
StonvexStonvexStonvexCore line items from DOW's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $39.97B | $42.96B | $44.62B | $56.90B |
Operating Income | $-2.51B | $1.60B | $656.00M | $6.09B |
Net Income | $-2.44B | $1.20B | $660.00M | $4.64B |
EPS (Diluted) | $-3.70 | $1.57 | $0.82 | $6.28 |
Total Assets | $58.54B | $57.31B | $57.97B | $60.60B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $3.82B | $2.19B | $2.99B | $3.89B |
Free Cash Flow OCF − CapEx | $-1.45B | $-26.00M | $2.84B | $5.65B |
Shares Outstanding | 711.60M | 705.10M | 709.00M | 725.60M |